BASF SE (BAS.F), Tuesday announced an agreement to sell its optical brightening agent business to Catexel, a Care Chemicals platform of the International Chemical Investors Group. The financial details of the deal were not disclosed.
The transaction is part of BASF's 'Winning Ways' strategy, which aims to actively manage the company's portfolio and drive prioritization.
Set to close in the first quarter of 2026, the deal comprises of optical brightening agents at the Monthey site in Switzerland and approximately 80 employees.
Currently, BASF's stock is trading at 44.44 euros, up 0.54 percent on the Frankfurt Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.